TOP > 外国特許検索 > NON-HUMAN MAMMAL MODEL FOR NORMAL TENSION GLAUCOMA

NON-HUMAN MAMMAL MODEL FOR NORMAL TENSION GLAUCOMA UPDATE

外国特許コード F130007328
整理番号 S2011-0498-C0
掲載日 2013年4月26日
出願国 世界知的所有権機関(WIPO)
国際出願番号 2012JP056627
国際公開番号 WO 2012124752
国際出願日 平成24年3月15日(2012.3.15)
国際公開日 平成24年9月20日(2012.9.20)
優先権データ
  • 特願2011-057926 (2011.3.16) JP
発明の名称 (英語) NON-HUMAN MAMMAL MODEL FOR NORMAL TENSION GLAUCOMA UPDATE
発明の概要(英語) The present invention provides a genetically modified non-human mammal where a mutation, substituting Asp or Glu for the Ser that is the Cdk5 phosphorylation site of the c-Src protein, has been introduced into the Src gene. Provided thereby is a novel non-human mammal and the like which can be used as a model for normal tension glaucoma.
従来技術、競合技術の概要(英語) BACKGROUND ART
Glaucoma, optic nerve is damaged for some reason, the field of progressive disease and are damaged, is left as it is, ultimately leading to a high possibility that the blindness.
1 A high intraocular pressure glaucoma is one of glaucoma, the anterior chamber is deteriorated and the excretion of aqueous humor in the eye pressure (intraocular pressure) by the increase in the optic nerve atrophy and is pressed, visual function so that fluid is damaged, a field of view is narrowed disease.
Normal tension glaucoma is, from a height of prevalence, are of particular interest in the recent disease. And about 400 million Japanese glaucoma patients, of which about 3 one-half the normal tension glaucoma patient 2. Is normal tension glaucoma, normal intraocular pressure (in humans usually 10-21mmHg) even though not, finding similar to that of the high intraocular pressure glaucoma (optic nerve atrophy and loss of vision) and exhibits a disease state, specifically, not accompanied by inflammation of the nerve can be (a), (b) lesion is retinal ganglion cell (RGC: retinal ganglion cell) be restrictive, (c) a nervous disorder to proceed over time, the optic papilla (d) characteristic findings have (recessed), (e) maintained in a normal eye pressure, which is characteristic of the such as. Is normal tension glaucoma, slow the progress of the subjective symptom is small, early detection is difficult, also at present, other than to lower eye pressure further, and therapy is not determined.
Normal tension glaucoma model non-human mammal is obtained, useful in the treatment of normal tension glaucoma therapeutic agent for the development of, the establishment of a method for the treatment, and a cause of the disease and also for elucidation of the pathogenesis, expected to be extremely valuable.
Here, as a model mouse normal tension glaucoma, the anterior chamber and the ablation laser exhaust path (non-patent document 1), placing a bead the anterior chamber (non-patent document 2), the vein is solidified so that the discharge of aqueous (non-patent document 3) as, and the like are known. However, any of the model, it is difficult to adjust in intraocular pressure, can be associated with inflammation, can be a contradiction in the pathogenesis, such as a problem.
In addition, GLAST gene were deleted normal tension glaucoma also known model mouse (non-patent document 4, patent document 1). Is GLAST, nerve information possibly because the collecting mechanism known as metabotropic glutamate transporter in.
As normal tension glaucoma model mouse, the progress of a condition including is gradual, actual human normal tension glaucoma in the same manner as of the onset of symptoms similar to mechanism is demanded.
  • 出願人(英語)
  • ※2012年7月以前掲載分については米国以外のすべての指定国
  • UNIVERSITY OF YAMANASHI
  • 発明者(英語)
  • KASHIWAGI Kenji
  • KATO Goro
国際特許分類(IPC)
指定国 National States: AE AG AL AM AO AT AU AZ BA BB BG BH BR BW BY BZ CA CH CL CN CO CR CU CZ DE DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LA LC LK LR LS LT LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PE PG PH PL PT QA RO RS RU RW SC SD SE SG SK SL SM ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA RW SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ MD RU TJ TM
EPO: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG
上記の特許・技術に関心のある方は、下記問合せ先にご相談下さい。

PAGE TOP

close
close
close
close
close
close